Early morbidity and dose–volume effects in definitive radiochemotherapy for locally advanced cervical cancer: a prospective cohort study covering modern treatment techniques
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1439-099X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Early morbidity and dose–volume effects in definitive radiochemotherapy for locally advanced cervical cancer: a prospective cohort study covering modern treatment techniques ; volume:197 ; number:6 ; day:30 ; month:4 ; year:2021 ; pages:505-519 ; date:6.2021
Strahlentherapie und Onkologie ; 197, Heft 6 (30.4.2021), 505-519, 6.2021
- Urheber
-
Seppenwoolde, Yvette
Majercakova, Katarina
Buschmann, Martin
Dörr, Elke
Sturdza, Alina E.
Schmid, Maximilian P.
Pötter, Richard
Georg, Dietmar
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00066-021-01781-6
- URN
-
urn:nbn:de:101:1-2021092220093477517882
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 05:23 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Seppenwoolde, Yvette
- Majercakova, Katarina
- Buschmann, Martin
- Dörr, Elke
- Sturdza, Alina E.
- Schmid, Maximilian P.
- Pötter, Richard
- Georg, Dietmar
- SpringerLink (Online service)
Ähnliche Objekte (12)
Neoadjuvant versus definitive radiochemotherapy of locoregionally advanced oesophageal cancer—who benefits?
ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
Retrospective Study of Neoadjuvant Versus Adjuvant Radiochemotherapy in Locally Advanced Noninflammatory Breast Cancer : Survival Advantage in cT2 Category by Neoadjuvant Radiochemotherapy
Comparison of weekly administration of cisplatin versus three courses of cisplatin 100 mg/m2 for definitive radiochemotherapy of locally advanced head-and-neck cancers
Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer
Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on Neoadjuvant Chemotherapy Prior to Definitive Radiochemotherapy in Patients with Locally Advanced Cervical Cancer
Radiochemotherapy in esophageal cancer
Neck control after definitive radiochemotherapy without planned neck dissection in node-positive head and neck cancers
microRNAs expression profile related with response to preoperative radiochemotherapy in patients with locally advanced gastric cancer
Concurrent radiochemotherapy in locally-regionally advanced oropharyngeal squamous cell carcinoma: analysis of treatment results and prognostic factors
Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity
Neoadjuvant versus definitive radiochemotherapy of locoregionally advanced oesophageal cancer—who benefits?
ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
Retrospective Study of Neoadjuvant Versus Adjuvant Radiochemotherapy in Locally Advanced Noninflammatory Breast Cancer : Survival Advantage in cT2 Category by Neoadjuvant Radiochemotherapy
Comparison of weekly administration of cisplatin versus three courses of cisplatin 100 mg/m2 for definitive radiochemotherapy of locally advanced head-and-neck cancers
Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer
Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on Neoadjuvant Chemotherapy Prior to Definitive Radiochemotherapy in Patients with Locally Advanced Cervical Cancer
Radiochemotherapy in esophageal cancer
Neck control after definitive radiochemotherapy without planned neck dissection in node-positive head and neck cancers
microRNAs expression profile related with response to preoperative radiochemotherapy in patients with locally advanced gastric cancer
Concurrent radiochemotherapy in locally-regionally advanced oropharyngeal squamous cell carcinoma: analysis of treatment results and prognostic factors
Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity
Neoadjuvant versus definitive radiochemotherapy of locoregionally advanced oesophageal cancer—who benefits?
ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
Retrospective Study of Neoadjuvant Versus Adjuvant Radiochemotherapy in Locally Advanced Noninflammatory Breast Cancer : Survival Advantage in cT2 Category by Neoadjuvant Radiochemotherapy
Comparison of weekly administration of cisplatin versus three courses of cisplatin 100 mg/m2 for definitive radiochemotherapy of locally advanced head-and-neck cancers
Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer
Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on Neoadjuvant Chemotherapy Prior to Definitive Radiochemotherapy in Patients with Locally Advanced Cervical Cancer
Radiochemotherapy in esophageal cancer
Neck control after definitive radiochemotherapy without planned neck dissection in node-positive head and neck cancers
microRNAs expression profile related with response to preoperative radiochemotherapy in patients with locally advanced gastric cancer
Concurrent radiochemotherapy in locally-regionally advanced oropharyngeal squamous cell carcinoma: analysis of treatment results and prognostic factors